Navigation Links
USC Center For Applied Molecular Medicine To Honor Sumner Redstone And Murray Gell-Mann, Ph.D. At The Inaugural REBELS WITH A CAUSE Gala
Date:9/18/2012

LOS ANGELES, Sept. 18, 2012 /PRNewswire/ -- USC Center for Applied Molecular Medicine honors Sumner M. Redstone and Nobel Laureate Murray Gell-Mann, Ph.D. at its REBELS WITH A CAUSE gala, September 19, 2012, at the Four Seasons Los Angeles at Beverly Hills.  The evening will raise funds to support the lifesaving research of David B. Agus, M.D., Director, USC Westside Cancer Center and USC Center for Applied Molecular Medicine.  Carmen A. Puliafito, M.D., M.B.A., Dean, Keck School of Medicine of USC is Honorary Co-Chair; Beverly and Robert Cohen Co-Chair.  The gala will feature performances by Tony Bennett and Neil Young; Tracey Ullman, emcees.

Sumner M. Redstone, Executive Chairman of Viacom and CBS Corporation has been Chairman of the Board of National Amusements since 1986, and CEO since 1967. He is a member of the Advisory Council for the ATAS Foundation and is on the Board of Trustees for The Paley Center for Media. He also served as COB of the National Association of Theatre Owners, and is currently a member of its Executive Committee. Before that, he was President of the Theatre Owners of America. Mr. Redstone was recently honored with a star on the Hollywood Walk of Fame. Mr. Redstone has devoted himself to a wide variety of civic and community affairs efforts, contributing over $150 million to worthy charities.

Murray Gell-Mann, Ph.D., is a Distinguished Fellow at the Santa Fe Institute as well as the Robert Andrews Millikan Professor Emeritus at the California Institute of Technology. In 2010, he was appointed Presidential Professor of physics and medicine at USC. In 1969 he received the Nobel Prize in physics for his work on the theory of elementary particles.  He is the author of The Quark and the Jaguar.

The goal of the USC Center for Applied Molecular Medicine is the development of novel treatment strategies for cancer.  The Center was implemented to enable multiple disciplines to work on treatment and the care of patients with cancer.  The program includes the clinical care of patients at the USC Westside Cancer Center and has team members with expertise spanning cancer biology, biochemistry, molecular biology, bioinformatics, computer science, electrical engineering, bioorganic chemistry, physics and applied mathematics.  http://camm.usc.edu/.


'/>"/>
SOURCE USC Center for Applied Molecular Medicine
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. University of Kentucky Medical Center Transplants States 1st SynCardia Total Artificial Heart Patient
2. MD Anderson Cancer Center joins Actinium Pharmaceuticals (API) Multicenter Actimab-A Trial
3. New UCLA Engineering research center to revolutionize nanoscale electromagnetic devices
4. Center will create self-powered health monitoring devices
5. Allergan Opens New Research and Development Center in Bridgewater, New Jersey
6. Tufts Medical Center Announces Inaugural INNOVATION Day: Innovating a Path to Market
7. Texas Medical Center, the largest concentration of medical research, educational and healthcare organizations in the world, announces the first Houston Stem Cell Summit to highlight the latest stem cell research and commercialization efforts
8. New Physician Joins Dallas Based Fertility Center
9. The Law Office of Roger G. Worthington, P.C. - Longtime Supporter of the Pacific Meso Center - Donates $100,000 for Mesothelioma Research
10. Breathe Better With Clarity Allergy Center
11. InVigor® Canola Supports Langdon Day Care Center with More for Everyone Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... Newly created ... services and solutions to the healthcare market. The company's primary focus is on ... sales and marketing strategies that are necessary to help companies efficiently bring their ...
(Date:6/24/2016)... , June 24, 2016 Epic ... sensitively detects cancers susceptible to PARP inhibitors by ... tumor cells (CTCs). The new test has already ... therapeutics in multiple cancer types. Over ... DNA damage response pathways, including PARP, ATM, ATR, ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)... -- The Prostate Cancer Foundation (PCF) is pleased to announce 24 new ... prostate cancer. Members of the Class of 2016 were selected from a pool ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
Breaking Biology Technology:
(Date:4/19/2016)... , UAE, April 20, 2016 ... implemented as a compact web-based "all-in-one" system solution for ... biometric fingerprint reader or the door interface with integration ... modern access control systems. The minimal dimensions of the ... readers into the building installations offer considerable freedom of ...
(Date:4/14/2016)... 14, 2016 BioCatch ™, ... today announced the appointment of Eyal Goldwerger ... Goldwerger,s leadership appointment comes at a time ... the deployment of its platform at several of the ... which discerns unique cognitive and physiological factors, is a ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys ... founding CEO, Barrett Bready , M.D., who returned ... of the original technical leadership team, including Chief Technology ... of Product Development, Steve Nurnberg and Vice President of ... to the company. Dr. Bready served as ...
Breaking Biology News(10 mins):